Results 111 to 120 of about 102,335 (146)
Some of the next articles are maybe not open access.
AJN, American Journal of Nursing, 1974
None of the extracorporeal perfusion systems equals the perfection of the human heart and lung. Therefore, physiological changes occur during and after surgery which may affect the patient's postoperative course and treatment. There are significant changes in the patient's clotting mechanism.
M L, Long+2 more
openaire +5 more sources
None of the extracorporeal perfusion systems equals the perfection of the human heart and lung. Therefore, physiological changes occur during and after surgery which may affect the patient's postoperative course and treatment. There are significant changes in the patient's clotting mechanism.
M L, Long+2 more
openaire +5 more sources
Apoptosis and Cardiopulmonary Bypass
Journal of Cardiac Surgery, 2007The aim of this study was to ascertain the percentage of apoptotic myocytes in patients who underwent coronary artery bypass surgery. Apoptotic index (AI) obtained with in situ terminal deoxynucleotidyl transferase-labeled dUTP nick end labeling (TUNEL) method and Bak protein expression were compared.Twenty consecutive patients who underwent coronary ...
Kovačević, Miljenko+3 more
openaire +5 more sources
Current Opinion in Cardiology, 1991
There has been a recent renewed interest in certain aspects of cardiopulmonary bypass employing extracorporeal circulation. Several areas have received special attention. Among these is the institution of extracorporeal circulation using a percutaneous technique for circulatory assistance during high-risk percutaneous transluminal coronary ...
V A, Ferraris+3 more
openaire +2 more sources
There has been a recent renewed interest in certain aspects of cardiopulmonary bypass employing extracorporeal circulation. Several areas have received special attention. Among these is the institution of extracorporeal circulation using a percutaneous technique for circulatory assistance during high-risk percutaneous transluminal coronary ...
V A, Ferraris+3 more
openaire +2 more sources
The platelet in cardiopulmonary bypass [PDF]
Platelets are the smallest of the blood cells and are known to be activated during cardiopulmonary bypass. They play a role in many associated complications. Both quantitative and qualitative platelet defects have been demonstrated, resulting in microvascular hemorrhage and thromboembolism.
Arjuna Weerasinghe, Kenneth M. Taylor
openaire +2 more sources
Cardiopulmonary bypass in pregnancy
The Annals of Thoracic Surgery, 1996The cardiopathic patient can sustain acute heart failure during pregnancy. In such cases, if open heart operation is necessary to save the patient's life, the fetus could be seriously compromised after exposure to cardiopulmonary bypass. From 1958 to 1992, 69 reports of cardiac operations during pregnancy with the aid of cardiopulmonary bypass have ...
POMINI FRANCESCO+4 more
openaire +5 more sources
Pediatric cardiopulmonary bypass
The Annals of Thoracic Surgery, 20011. Jaggers J, Shearer IR, Ungerleider RM. Cardiopulmonary bypass in infants and children. In: Gravlee G, ed. Cardiopulmonary bypass: principals and practice. New York: Lippencott, Williams and Wilkins, 2000. 2. Gaynor JW, Kern FH, Greeley WJ, et al. Management of cardiopulmonary bypass in infants and children.
John L. Myers, Edward R. Stephenson
openaire +3 more sources
Miniaturization in cardiopulmonary bypass
Perfusion, 2003Cardiopulmonary bypass (CPB) remains the key technology for more complex cardiac operations. The perfusion equipment used nowadays has seen tremendous progress since its introduction into clinical practice 50 years ago. However, overall, CPB is still far from perfect.
Ludwig K. von Segesser+5 more
openaire +3 more sources
The coagulopathy of cardiopulmonary bypass
Critical Reviews in Clinical Laboratory Sciences, 2010There have been numerous publications on the coagulopathy of cardiopulmonary bypass (CPB). This review provides an introduction to the history and main components of current CPB circuits and summarizes the current knowledge of pathogenesis, prevention, and treatment of the CPB coagulopathy.
Andrew A. Klein, Martin Besser
openaire +3 more sources
Biomaterials in cardiopulmonary bypass
Perfusion, 1994The improved utilization of biomaterials in cardiopulmonary bypass is dependent on polymer science and technology, procedures for blood compatibility assessment, optimization of biomaterial/antithrombotic agent combinations and the interpretation of clinical data.
John D. S. Gaylor+4 more
openaire +3 more sources
Neonatal Cardiopulmonary Bypass
Seminars in Thoracic and Cardiovascular Surgery: Pediatric Cardiac Surgery Annual, 2013Cardiac surgery with cardiopulmonary bypass is routinely used in neonates who require early repair of congenital heart diseases. However, the bypass temperature and use of deep hypothermic circulatory arrest, the composition of the priming and the acceptable degree of hemodilution, the prophylactic use of antifibrinolytic agents and steroids, the ...
Philippe Pouard, Mirela Bojan
openaire +3 more sources